Discussion Paper - Review of the National Industrial Chemicals Notification and Assessment Scheme: June 2012

Submission Form - Review of the National Industrial Chemicals Notification and Assessment Scheme: June 2012

Page last updated: 30 March 2012

PDF printable version of Discussion Paper - Review of the National Industrial Chemicals Notification and Assessment Scheme: June 2012 (PDF 466 KB)

HTML version of Discussion Paper - Review of the National Industrial Chemicals Notification and Assessment Scheme: June 2012

HTML version of 'Making a submission form'

Word version of 'Making a submission form' (Word 332 KB)

Making a submission

Submissions must be received by the Department of Health and Ageing by
5pm, Friday 27 July 2012


Please use this form to make your submission in response to the discussion paper. You may delete any sections that you do not wish to comment on.

While submissions may be lodged electronically or by post, electronic lodgment by email is preferred. For accessibility reasons, please email responses in a Word or RTF format not as a .pdf.

Email: NICNAS review (NICNAS.review@health.gov.au)

Mail:
NICNAS Review
Department of Health and Ageing (MDP 71)
GPO Box 9848
CANBERRA ACT 2601

Organisation or Individual:
Principal contact:
Position:
Phone:
Fax:
Mobile:
Email address:

Street address:
Suburb/City:
State:
P'code:

Postal address:
Suburb/City:
State:
P'code:

Please note:
  • For submissions made by individuals, all personal details other than your name and the state or territory in which you reside will be removed from your submission before it is published on the Department of Health and Ageing website.
  • Copyright in submissions resides with the author(s), not with the Australian Government.
  • Submissions, or parts thereof, that are intended to remain confidential should be clearly marked as such and justifications provided. Submitters should be aware that confidential submissions may still be subject to access under freedom of information law.
  • Submissions will be made public and shared with relevant Commonwealth agencies and any consultants engaged to assist with the review.
  • Submissions will remain on our website as public documents indefinitely.

Confidentiality

Please indicate if your submission:
  • contains no material supplied in confidence
  • contains in confidence material which is clearly marked as such

Summary

Please provide a short summary, up to half a page, outlining the key points of your submission:Top of Page

Part 4 – The regulatory framework for industrial chemicals (options A1 – A3)

  • Do you think that an industrial chemicals risk assessment and risk management manual would assist? If not, why not?
  • If so, what are the specific matters that could usefully be addressed in the manual?
  • What are the strengths and weaknesses of the options?
Please keep your responses to each option no more than one page:

Part 5 – New industrial chemicals (options B1-B6)

  • What are the strengths and weaknesses of the options for addressing the problems and objectives identified?
  • If weaknesses are identified in relation to any of the options, are there other options that also meet the objectives?
  • If these options were to be adopted, what are some of the implementation issues that would require consideration?
  • What would be the likely impact on your organisation, if this approach were adopted?
  • If NICNAS were able to refuse both an assessment certificate (Option B4) or listing on AICS (Option B5), under what circumstances would this be appropriate?
Please keep your responses to each option to no more than one page:

Part 6 – Existing industrial chemicals (options C1-C6)

  • Do these options address the problems identified in relation to existing chemicals? If not, why not?
  • What are the implementation implications?
  • If these options were (or were not) to be adopted, how would this impact on your organisation?
Please keep your responses to each option to no more than one page:

Part 7 – Post market monitoring and enforcement (Options D1-D3)

  • What are the strengths and weaknesses of the options?
  • Does an adverse effects reporting system address the problems and objectives identified?
  • What would be the impact of an adverse effects reporting system on introducers?
  • Are there other ways in which NICNAS’ post-market monitoring and enforcement capacity could be improved?
Please keep your responses to each option to no more than one page:

Part 8 – Other reforms – release of information and confidential commercial information (Options E1-E2)

  • How would the release of information to other relevant government agencies impact introducers?
  • What are some of the implementation issues that would require consideration?
  • What would be the impact of these options?
  • Are there any other ways in which the identified problems can be addressed?
Please keep your responses to each option to no more than one page:Top of Page

Part 8 – Other reforms – use of foreign schemes / international assessments (Options F1-F2)

  • Do these options strike an appropriate balance between the use of international assessments/harmonisation and the need to ensure that Australia retains the capacity to undertake Australian relevant risk assessment and management where necessary?
  • If these options were to be adopted, what are the implications?
  • If these options were (or were not) adopted, how would this impact on your organisation?
Please keep your responses to each option to no more than one page:

Part 8 – Other reforms – chemicals in articles (Options G1-G2)

  • Do these options address the problems relating to articles?
Please keep your responses to this option to no more than one page:

Part 8 – Other reforms – chemicals in cosmetics (Option H1-H2)

  • If these options were (or were not) to be adopted, how would this impact on your organisation?
Please keep your responses to this option to no more than one page:

Part 8 – Other reforms – Import and export of chemicals under the Stockholm and Rotterdam Conventions (Option I1-I2)

  • What are the implications of maintaining the status quo?
Please keep your responses to this option to no more than one page:

Part 8 – Other reforms – Governance – Committees (Option J1)

  • If the options in this Discussion Paper are preferred, what does this mean for the governance committees of NICNAS?
  • What committees are needed? For example, would it be useful to have a strategic advisory committee advising the Director of NICNAS?
Please keep your responses to this option to no more than one page:

Part 8 – Other reforms – Governance – Relationship with the Department of Health and Ageing (DoHA) (Option K1)

Please keep your responses to this option to no more than one page:Top of Page